All Resources
App Note
Proteomic Barcoding Product Suite for Tumor Resistance

Learn how our single-cell signaling reveals coordinated signals from tumor cells driving resistance.

Your data is secure. We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from Bruker Cellular Analysis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this App Note we discuss:

Overcoming challenges in tumor resistance
Early signs of drug resistance in rare melanoma cells
Informing targeted combination therapy to overcome resistance in glioblastoma (GBM)
Elucidating mechanisms of tumorigenesis
Resolving tumor heterogeneity to reveal independent trajectories of drug tolerance
A Deeper Look

More about this App Note

Overcoming Challenges in Tumor Resistance

A major challenge in the field of cancer immunology is that tumor cells can develop resistance to targeted therapies.

Download this App Note to learn how PhenomeX helps researchers understand the impacts of their therapies earlier in development and the mechanisms behind therapy resistance in oncology research.

Get the App Note